IMO this company is highly vulnerable to a buyout. If it would happen it would be much more than the present price, but not any where near what it coukd have been if their wasn't the mess-up. t
I believe that these CA drugs, at least RX-3117 will best underestimated by wall street while all of those PD-1 inhibitors will be over-estimated in regards to their value in treating CA. t
I have been following this stock for over twenty years. I've talked to the people from ISIS, watched that competition, etc. I feel very comfortable for the future based on the companies....and Dr. Crookes persistence to improve the technology to the point where they are in a commanding position/lead. No Mab's are going to be able to come up with next generation drugs. They will cost more to discover, and produce as well. As for the chums, I thank them for the reverse Voo-Doo and wish them well. They will be living on a commune soon and will be out of the picture. I hope that all ISIS longs remember that and give them a break. As the year progresses this will become increasingly clear. So I can just say when you see their nonsense and other insults of desperation that we cut them a break. They want to drive a BMW and they will be destined to be driving horse-drawn carriages.......nothing wrong with that. GLTA's, and God bless the Chums and their chosen life down on the commune. t
Lifevantage announces that Vice President of Product Development Nathalie Chevreau, PhD is presenting a poster abstract at the Experimental Biology 2015 Boston meeting (0.81)
The poster highlights a portion of the findings from clinical research being conducted by LifeVantage on its Canine Health product, a Nrf2 Synergizer for dogs.
The findings from the research show a decrease in oxidative stress in dogs that have taken Canine Health over a period of 60 days. The studies also demonstrate improved physical performance in the dogs taking Canine Health. These improvements include greater mobility, faster running times, decreased stiffness, and increased energy levels when compared to dogs taking a placebo.
Number one is wrong. Vicl's last drug did worse than the placebo.....tranlates as harmful. Number two is wrong, VICL has only five drugs in their pipeline. Number three is wrong as last year vj was voted one of the worst biotech CEO's. He almost faced criminal charges. Dr. Crooke received several biotech awards. Including one associated with his work for children with ISIS SMA drug. No one wants VICL shares, Astellas took some shares as they fed VICL pxx-pxx.
I don't think trying to lie to people and recommend an investment that lost over 89% of its value is helping anyone. The chums are a jealous bunch but their Voo-Doo has worked magic for ISIS. With the huge amount of money that ISIS shareholders have they will be able to donate to the charity of their choice. If one of the chums donates one share of vicl a child could receive a Popsicle. So in your own way you've shown others the right way and that is to invest in ISIS so I thank you for that. They've seen the lying about the $200 per share for ISIS and other lies. This has helped the unbiased investor make their way to ISIS. Again thank you. Please if you do resort to commune living please leave an mailing address and some of us may make a donation to the commune. t
You are speculating that people who try and trade will do well. How about like on the CNBC commercial you give everyone a $100 K to trade for you and like that guy in the commercial we get to keep 60%.......I would bet that the average trader even trying with your money would lose everything. You are giving the most extreme in danger as far as encouraging trading. The little meek RNN could inherit the CA earth. The traders will all be long gone. t
You stated what you had to say for maybe the 100th time. I think you are jealous and don't want anyone to be successful. Also, it is a well known fact that the average "successful" trader sits over a hot screen all day and makes about $350 bucks. t
You are looking bad dude. I don't know you like the rest of the chums. Any one can look up that vicl hit over $59 in the year 2000. ISIS has never hit $200 and it's high was just a month ago. All of the chums have pumped vicl so again that is not truth. Any prediction for vicl has been an on-going thing for well over four years. In fact sour and some of the chums were predicting when vicl would pass ISIS in price......never happened. If Cramer or anyone would say something bad about ISIS you'd be right there. How don't know how long long term visionary is, but so far since the year 2000 vicl has had a long term vision that can be followed via a chart down from 59 to less than a buck. What is interesting about that is the best news vicl can dig up is to buy a fungal drug cast-off from Astellas. A drug that is completely away from their core that they have no experience in. OGXI no matter what you say about still goes for more than vicl and has more going for it than vicl. Their problem is that they are not the Tower of Power like ISIS is. Their technological platform is behind ISIS by about six years........But everyone in vaccines is ahead of vicl. I suggest you look at the last sentence you wrote too. Astellas may have fed vicl pxx-pxx with their sale to vulnerable vicl. Thank you again though for the reverse Voo-Doo to help ISIS we'll talk plenty over the next six months. Please get those heavy duty undies on for your spankings too. Thanks again. t
"Dude" I think you could be alittle mistaken. If Astellas wanted vicl they would have bought them already......unless of course they think that they are going down further. More likely Astella used vicl as a burying ground for that antifungal drug, or that the very least the de-risked their situation by passing it off to a very weak player with no experience in that field. You have my vote to drive the Italian cruise liner of biotech vicl. Good luck to you. t
You guys own a lot of vicl already. Why don't you and the chums just buyout vicl and insert "the dude" as CEO?? t
Big I know you always struggled in math class and wanted to go to college and couldn't, so you get a get out of jail card for free for life based on your situation. Please obtain those double underalls for protection over the next few months for the spankings, and soiling that you will have take place. Good luck to you though. t
For a med that treats Huntington's Disease symptoms. Makes one wonder the value of ACAD's drug? t
ISIS drug for Huntington's Disease is the only drug to really hit the disease directly. So whatever TEVA is paying.....now over $100 bucks per share for a company with less than four drugs, ISIS Huntington's Disease drug is probably worth more. t
CLDN is going to have competition in regards to their heart failure drug. I know you didn't post this link based on that, but if someone is pursuing them they should know that NVS has their heart failure drug as does MSTX. The drug from MSTX isn't a permanent fix but their data looks very intriguing and with stem cell technology you are talking huge costs. Thus CLDN might put themselves in a GILD type of situation.....that being trying to charge huge prices for a drug that treats the masses, definitely not an orphan drug space. t